Access to Insight Logo

The Access to Insight Grants Core Faculty is pleased to announce Access to Insight – the Novo Nordisk Haemostasis Grants Initiative, which offers exciting funding opportunities specially tailored to the needs of talented haemostasis physicians and researchers.

Novo Nordisk, a healthcare company with a leading position in haemostasis management, is strongly committed to supporting haemostasis research and education.

The initiative is steered by the Access to Insight Grants Core Faculty, a group of distinguished haemostasis experts co-chaired by Margareth Castro Ozelo, MD, PhD, Professor and Director of the WFH International Haemophilia Training Centre (IHTC), Hemocentro UNICAMP, Chief of the Hematology Division, University of Campinas (UNICAMP), Campinas, in Brazil and David Lillicrap, MD, FRCPC, Professor at the Department of Pathology and Molecular Medicine, Queen’s University in Kingston in Canada.

Overview of Access to Insight funding opportunities

Basic Research Grant

  • up to € 70,000
  • 12–18 month period
  • Focus: Basic science or translational
    research relevant to the under-
    standing of the pathophysiology
    and treatment of haemostatic
    disorders

Clinical Research Grant

  • up to € 70,000
  • 12 month period
  • Focus: Innovative haemostatic
    research on patient outcomes,
    quality of life, and social impacts

Newsletter

Access to Insight
Changing haemophilia Novo Nordisk